Cargando…
Nanoparticles advanced from preclinical studies to clinical trials for lung cancer therapy
Lung cancer is the leading cause of cancer mortality. As a heterogeneous disease, it has different subtypes and various treatment modalities. In addition to conventional surgery, radiotherapy and chemotherapy, targeted therapy and immunotherapy have also been applied in the clinics. However, drug re...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Vienna
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042676/ https://www.ncbi.nlm.nih.gov/pubmed/37009262 http://dx.doi.org/10.1186/s12645-023-00174-x |